Funding innovative projects for cancer epigenetic therapies
Official title: Developmental Research Program
Funded at Coriell Institute for Medical Research · NIH-10886794 · Data updated 2026-11-12
This study is looking for new ways to treat cancer by exploring how changes in our genes can affect the disease, and it's designed to help scientists work together to find better therapies that could benefit patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Coriell Institute for Medical Research NIH-funded |
| Lab location | 1 site (Camden, United States) |
| Project start | August 16, 2021 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $85,197 |
| NIH project number | 5P50CA254897-04 |
| Project ID | NIH-10886794 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals diagnosed with hematologic cancers or other malignancies that may be influenced by epigenetic changes.
✕Less likely to help
Patients with non-cancerous conditions or those whose cancers are not influenced by epigenetic mechanisms may not benefit from this research.
What this research studies
This program aims to support pilot studies focused on developing and improving epigenetic therapies for various cancers. It encourages collaboration between scientists and institutions to foster innovative research in this area. By providing funding and resources, the program seeks to identify promising projects that can lead to significant advancements in cancer treatment. Patients may benefit from new therapies that target the epigenetic mechanisms involved in cancer progression.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking epigenetic therapies that improve cancer treatment outcomes.
How similar studies have gone: Previous research has shown promise in developing epigenetic therapies for cancer, indicating a potential for success in this innovative approach.
Where this research is happening
-
Coriell Institute for Medical Research
Camden, United States Active
Researchers
- Principal investigator: Issa, Jean-Pierre J. — Coriell Institute for Medical Research
- Study coordinator: Issa, Jean-Pierre J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.